Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: A cross-sectional study in Southern Brazil

Brazilian Journal of Medical and Biological Research

Volumn 35, Issue 10, 2002, Pages 1173-1181

  Pinheiro, C A T ^a   de Carvalho Leite, J C ^b   Drachler, M L ^c,d   Silveira, V L ^a  

^a Universidade Federal de Pelotas Faculdade de Medicina   (Brazil)

^b UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^c Universidade Caxias do Sul   (Brazil)

^d UNIVERSIDADE DO VALE DO RIO DOS SINOS   (Brazil)

Author keywords

Adherence; AIDS; Antiretroviral therapy; HIV; Self efficacy

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BRAZIL; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; EDUCATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MOTIVATION; MULTIVARIATE ANALYSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT INFORMATION; PREDICTION; PRESCRIPTION; PREVALENCE; QUESTIONNAIRE; RATING SCALE; SELF CONCEPT; SELF REPORT; SOCIAL ASPECT;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0036818264     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2002001000010     Document Type: Article

References (39)

1. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT & Montaner JS (1998). Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. Journal of the American Medical Association, 279: 450-454.
2. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ & Holmberg SD (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338: 853-860.
3. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio-Monforte A, Yust I, Brun JN, Phillips AN & Lundgren JD (1998). Changing patterns of mortality across Europe in patients infected with HIV. Lancet, 3521: 1725-1730.
4. Coordenação Nacional de DST/AIDS do Brasil (2002). A experiência do programa brasileiro de AIDS. Available at http://www.aids.gov.br/final/biblioteca/resposta/resp€panhol.pdf. Accessed September 6, 2002.
5. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM & Singh N (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133: 21-30.
6. Monforte A, Testa L, Adorni F, Chiesa E, Bini T, Moscatelli C, Abeli C, Rusconi S, Sollima S, Balotta C, Musicco M, Galli M & Moroni M (1998). Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection. AIDS, 12: 1631-1637.
7. Lucas GM, Chaisson RE & Moore RD (1999). Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine, 131: 81-87.
8. Descamps D, Flandre P, Calvez V, Peytavin G, Meiffredy V, Collin G, Delaugerre C, Robert-Delmas S, Bazin B, Aboulker JP, Pialoux G, Raffi F & Brun-Vezinet F (2000). Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072 Study Team). Journal of the American Medical Association, 283: 205-211.
9. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA & Moss A (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14: 357-366.
10. Gifford AL, Bormann JB, Shively MJ, Wright BC, Richman DD & Bozzette SA (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23: 386-395.
11. Zolopa AR, Shafer RW, Warford A, Montoya JG, Hsu P, Katzenstein D, Merigan TC & Efron B (1999). HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Annals of Internal Medicine, 131: 813-821.
12. Wainberg MA & Friedland G (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279: 1977-1983.
13. Morse EV, Simon PM, Coburn M, Hyslop N, Greenspan D & Balson PM (1991). Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science and Medicine, 32: 1161-1167.
14. Eldred LJ, Wu AW, Chaisson RE & Moore RD (1998). Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndrome, 18: 117-125.
15. Mothashari F, Riley E, Selwyn PA & Altice F (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in correctional facility. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18: 341-348.
16. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, Johnson D, Dube MP, Hwang JY & McCutchan JA (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS, 13: 1099-1107.
17. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B & Wu AW (2000). Self-reported adherence to antiretroviral medication among participants in HIV clinical trials; the AACTG Adherence Instruments. AIDS Care, 12: 255-266.
18. Kastrissios H, Suarez JR, Katzenstein D, Girard P, Sheiner LB & Blaschke TF (1998). Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS, 12: 2295-2303.
19. Gordillo V, Del Amo J, Soriano V & Gonzalez-Lahoz J (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13: 1763-1769.
20. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH & Yu VL (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care, 8: 261-269.
21. Kleeberger CA, Phair JP, Strathdee AS, Detels R, Kingsley L & Jacobson LP (2001). Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 26: 82-92.
22. Nemes MIB, Souza MM, Souza A, Grangeiro A, Souza RS & Lopes JF (2000). Prevalência da aderência e fatores associados. In: Ministério da Saúde do Brasil, Coordenação Nacional de DST AIDS (Editores), Aderência ao Tratamento por Anti-Retrovirais em Serviços Públicos no Estado de São Paulo. Ministério da Saúde do Brasil, Brasília, DF, Brazil, 65-101.
23. Kalichman SC, Ramachandran B & Catz S (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14: 267-273.
24. Catz SL, Kelly JA, Bogart LM, Benotsch EG & McAuliffe TL (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19: 124-133.
25. Tuldrà A, Fumaz CR, Ferrer MJ, Baynés R, Arnó A, Balagué M, Bonjoch A, Jou A, Negredo E, Paredes R, Ruiz L, Romeu, J, Sirera G, Tural C, Burger D & Clotet B (2000). Prospective randomized two-arm controlled study to determine the efficacy of specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 25: 221-228.
26. Samet JH, Libman H, Steger KA, Dhawan RK, Chen J, Shevitz AH, Dewees-Durk R, Levenson S, Kufe D & Craven DE (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus type 1: a cross-sectional study in a municipal hospital clinic. American Journal of Medicine, 92: 495-502.
27. Ickovics JR & Meisler AW (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50: 385-391.
28. Max B & Renslow S (2000). Management of adverse effects of antiretroviral therapy and medication adherence. Clinical Infectious Diseases, 30 (Suppl 12): S96-S116.
29. Bandura A (1995). On rectifying conceptual ecumenism. In: Maddux JE (Editor), Self-Efficacy, Adaptation, and Adjustment: Theory, Research, and Application. Plenum Press, New York, NY, USA, 347-375.
30. Leite JCC, Drachler ML, Centeno MO, Pinheiro CAT & Silveira VL (2002). Escala de auto-eficácia para adesão e tratamento para HIV/AIDS: desenvolvimento, confiabilidade e validade de construto. Psicologia Reflexão Crítica, 15: 121-133.
31. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD & Volberding PA (1996). HIV viral load markers in clinical practice. Nature Medicine, 2: 625-629.
32. Murri R, Ammassari A, Gallicano K, De Luca A, Cingolani A, Jacobson D, Wu AW & Antinori A (2000). Patient-reported non-adherence is related to protease inhibitor levels. Journal of Acquired Immune Deficiency Syndrome, 24: 123-128.
33. Bandura, A (1997). Self-Efficacy: The Exercise of Control. W.H. Freeman & Company, New York, NY, USA.
34. Gallant JE & Block DS (1998). Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among physicians and patients. Journal of the International Association of Physicians in AIDS Care, 4: 32-35.
35. Basen-Engquist K (1992). Psychosocial predictors of "safer-sex" behaviors in young adults. AIDS Education and Prevention, 4: 120-134.
36. Kasen S, Vaughn RD & Walter HJ (1992). Self-efficacy for AIDS preventive behaviors among tenth grade students. Health Education Quarterly, 19: 187-202.
37. O'Leary A, Shoor S, Lorig K & Holman R (1988). A cognitive behavior treatment for rheumatoid arthritis. Health Psychology, 7: 527-544.
38. Gilchrist LD & Schinke SP (1983). Coping with contraception: cognitive and behavioral methods with adolescent. Cognitive Therapy and Research, 7: 379-388.
39. Di Clementi CC, Prochaska JÁ & Gilbertini M (1985). Self-efficacy and self-change of smoking. Cognitive Therapy and Research, 9: 181-200.